Low vitamin B6 plasma levels, a risk factor for thrombosis, in inflammatory bowel disease: role of inflammation and correlation with acute phase reactants

Saibeni, Simone; Cattaneo, Marco; Vecchi, Maurizio; Zighetti, Maddalena Loredana; Lecchi, Anna; Lombardi, Rossana; Meucci, Gianmichele; Spina, Luisa; de Franchis, Roberto
January 2003
American Journal of Gastroenterology;Jan2003, Vol. 98 Issue 1, p112
Academic Journal
: ObjectivesIndividuals with inflammatory bowel disease (IBD) are at increased risk for thrombosis and vitamin deficiencies. Low plasma levels of vitamin B6 are an independent risk factor for thrombosis and may cause hyperhomocysteinemia, another recognized risk factor for thrombosis. The aim of this study was to evaluate vitamin B6 plasma levels in IBD patients.: MethodsWe studied 61 IBD patients: 32 with Crohn’s disease and 29 with ulcerative colitis. For each patient, three sex- and age-matched healthy control subjects were studied.: ResultsMedian vitamin B6 levels were significantly lower in IBD patients (22.0 pmol/L, range 3.6–231.0) than in controls (31.1 pmol/L, 3.7–363.4; p < 0.01). In all, 13.1% IBD patients and 5.5% controls had plasma vitamin B6 levels lower than the 5th percentile of distribution in normal controls (p < 0.05). Low vitamin B6 levels were significantly more frequent in patients with active disease than in patients with quiescent disease (seven of 26, 26.9%, vs one of 35, 2.9%; p < 0.001). Moreover, patients with active disease had significantly lower median vitamin B6 levels (13.4 pmol/L, range 3.6–124.0) than patients in a quiescent phase (27.0 pmol/L, 7.8–231.0; p < 0.001). Low vitamin B6 levels were significantly correlated with serum concentrations of C-reactive protein (r = −0.36, 95% CI = −0.59 to −0.09, p < 0.01) and α1-acid-glycoprotein (r = −0.37, 95% CI = −0.59 to −0.10, p < 0.01). Hyperhomocysteinemia was more frequent in patients with low vitamin B6 levels (three of eight, 37.5%) than in patients with normal levels (nine of 53, 17.0%; p = 0.18). There was no statistically significant correlation between vitamin B6 and homocysteine plasma levels (r = −0.13, 95% CI = −0.37 to +0.14, p = 0.33).: ConclusionsLow vitamin B6 plasma levels, an independent risk factor for thrombosis, are frequent in patients with IBD, especially those with active disease.


Related Articles

  • Vitamin B-12 deficiency. Hudson, Ben // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;6/5/2010, Vol. 340 Issue 7758, p1245 

    The article offers clinical information on vitamin B-12 deficiency. It discusses the clinical case of an 85-year-old man who was diagnosed with vitamin B-12 deficiency. The causes, treatment and monitoring of patients with vitamin B-12 deficiency are explained. The assessment of B-12 deficiency...

  • Probiotics and Immune Regulation of Inflammatory Bowel Diseases. Y. Cong; A. Konrad; N. Iqbal; C.O. Elson // Current Drug Targets - Inflammation & Allergy;Jun2003, Vol. 2 Issue 2, p145 

    Intestinal microflora play an important role in the pathogenesis of inflammatory bowel diseases (IBD). Certain probiotic bacteria provide beneficial effects for human health and intervention of IBD. Possible mechanisms underlying these effects are diverse and include many aspects of the...

  • Inflammatory Bowel Disease.  // Current Medical Literature: Gastroenterology;2003, Vol. 22 Issue 2, p54 

    Presents citations and clinicians' notes about inflammatory bowel disease. 'High prevalence of osteoporotic vertebral fractures in patients with Crohn's disease,' by J. Klaus, G. Armbrecht et al.; 'Primary chronic interstitial nephritis in Crohn's disease,' by H. Izzedine, J. Simon et al.

  • The treatment of inflammatory bowel disease in children. Wyllie, Robert; Sarigol, Samra // Clinical Pediatrics;Jul1998, Vol. 37 Issue 7, p421 

    Editorial. Discusses the treatment of inflammatory bowel disease in children. Symptoms of inflammatory bowel disease; Efficacy of metronidazole; Study on corticosteroid analogues; Nutritional intervention in Crohn's disease.

  • Inflammatory bowel disease. Galper, Charlotte; Cerda, James; Hanauer, Stephen B.; Peppercorn, Mark A.; Wexner, Steven D. // Patient Care;3/15/1998, Vol. 32 Issue 5, p81 

    Focuses on treatments for inflammatory bowel diseases (IBDs). Detailed information on ulcerative colitis (UC), crohn's disease (UC) and their treatments; Reference to nutritional therapy; Precautions with the use of corticosterioids for IBD patients; Indepth look at several therapies for IBD. ...

  • Prevalence of inflammatory bowel disease in British 26... Montgomery, S. M.; Morris, D. L.; Thompson, N.P.; Subhani, J.; Pounder, R.E.; Wakefield, A.J. // BMJ: British Medical Journal (International Edition);04/04/98, Vol. 316 Issue 7137, p1058 

    Presents information on a study investigating the prevalence of inflammatory disease in British 26 years olds. Characteristics of the subjects of the study; Methodology used in the study; Statistics on the result of the study.

  • Clarifications. Leidel, Jan // Deutsches Aerzteblatt International;12/9/2011, Vol. 108 Issue 49, p836 

    A letter to the editor is presented in response to the article "Vaccination Coverage in Immunosuppressed Patients--Results of a Regional Health Services Research Study," by Niels Teich and colleagues in the 2001 issue.

  • Technetium-99m autologous phagocyte scanning: a new imaging technique for inflammatory bowel disease. pullman, W.; Hanna, R.; Sullivan, P.; Booth, J.A.; Lomas, F.; Doe, William F. // British Medical Journal (Clinical Research Edition);7/19/1986, Vol. 293 Issue 6540, p171 

    Examines the use of technetium (Tc)-99m autologous phagocyte scanning in determining the inflammatory bowel disease. Occurrence of terminal ileal Crohn's disease; Detection of mucosal inflammation; Advantages of Tc phaghocyte scan.

  • Bacteroides fragilis Enterotoxin Gene Sequences in Patients with Inflammatory Bowel Disease. Prindiville, Thomas P.; Sheikh, Rafik A.; Cohen, Stuart H.; Tang, Yajarayma J.; Cantrell, Mary C.; Silva Jr., Joseph // Emerging Infectious Diseases;Mar/Apr2000, Vol. 6 Issue 2, p171 

    We identified enterotoxigenic Bacteroides fragilis in stool specimens of patients with inflammatory bowel disease and other gastrointestinal disorders. The organism was detected in 11 (13.2%) of 83 patients with inflammatory bowel disease. Of 57 patients with active disease, 19.3% were toxin...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics